Palomino Laboratories Inc.
PALX· OTC
PALXPalomino Laboratories Inc.
Filed Aug 14, 2024 · 10-Q · 45 days after period end · 0001213900-24-068823
| Metric | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|
| Net Income | $346.00 | -$4.25K | -$4.25K |
| EPS Diluted | -$0.01 | -$0.00 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palomino Laboratories Inc. · CIK 1938569 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 14, 2024 · 45 d after period end
